These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 6247984)

  • 41. [Theory of pathogenesis in primary hyperuricamia].
    Mertz DP
    Med Klin; 1975 Jul; 70(28-29):1187-98. PubMed ID: 170496
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunodeficiencies associated with errors in purine metabolism.
    Edwards NL
    Med Clin North Am; 1985 May; 69(3):505-18. PubMed ID: 3925260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in the activity of hypoxanthine and adenine phosphoribosyltransferase in patients with hyperuricaemia and gout.
    Boyle JA; Greene ML; Seegmiller JE
    Q J Med; 1971 Oct; 40(160):574-5. PubMed ID: 5157418
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyperuricemia and gout. Classification, complications and management.
    Boss GR; Seegmiller JE
    N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
    [No Abstract]   [Full Text] [Related]  

  • 45. Purines poison lymphocytes.
    Lancet; 1978 Dec; 2(8101):1188. PubMed ID: 82149
    [No Abstract]   [Full Text] [Related]  

  • 46. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Screening for enzyme abnormality causing hyperuricemia].
    Higashino K; Yamamoto T; Moriwaki Y
    Nihon Rinsho; 1991 May; 49(5):1009-15. PubMed ID: 1648630
    [No Abstract]   [Full Text] [Related]  

  • 48. Metabolic implications of the Lesch-Nyhan syndrome.
    Emmerson BT
    Aust N Z J Med; 1972 Feb; 2(1):88-90. PubMed ID: 4502722
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of de novo purine synthesis in lymphocyte transformation.
    Allison AC; Hovi T; Watts RW; Webster AD
    Ciba Found Symp; 1977; (48):207-24. PubMed ID: 415850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
    Torres RJ; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary immunodeficiencies: development and trends].
    Stoop JW; Zegers BJ
    Ned Tijdschr Geneeskd; 1986 Sep; 130(36):1592-5. PubMed ID: 3093903
    [No Abstract]   [Full Text] [Related]  

  • 52. Recent advances in the identification of enzyme abnormalities underlying excessive purine synthesis in man.
    Becker MA; Seegmiller JE
    Arthritis Rheum; 1975; 18(6 Suppl):687-94. PubMed ID: 173346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic defects and immunodeficiency disorders.
    Hirschhorn R
    N Engl J Med; 1983 Mar; 308(12):714-6. PubMed ID: 6402701
    [No Abstract]   [Full Text] [Related]  

  • 54. Phosphoribosylpyrophosphate and enzymes of purine metabolism in erythrocytes from young hyperuricemic males.
    van Maris AG; Tax WJ; Oei TL; de Bruyn CH; Klein F; Geerts SJ; Veerkamp JH; Valkenburg HA
    Biochem Med; 1980 Jun; 23(3):263-71. PubMed ID: 6158313
    [No Abstract]   [Full Text] [Related]  

  • 55. Alterations in purine metabolism in cultured fibroblasts with HGPRT deficiency and with PRPP synthetase superactivity.
    Zoref-Shani E; Sperling O
    Adv Exp Med Biol; 1979; 122B():19-24. PubMed ID: 232629
    [No Abstract]   [Full Text] [Related]  

  • 56. NAD synthesis in human erythrocytes: study of adenylyl transferase activities in patients bearing purine enzyme disorders.
    Sestini S; Pescaglini M; Magagnoli C; Jacomelli G; Rocchigiani M; Simmonds HA
    Adv Exp Med Biol; 1991; 309B():319-22. PubMed ID: 1664184
    [No Abstract]   [Full Text] [Related]  

  • 57. Normal uric acid concentrations in a purine nucleoside phosphorylase (PNP) deficient child presenting with severe chicken pox, possible immunodeficiency and developmental delay.
    Hallett RJ; Cronin SM; Morgan G; Duley JA; Fairbanks LD; Simmonds HA
    Adv Exp Med Biol; 1994; 370():387-9. PubMed ID: 7544949
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ; Prior C; Puig JG
    Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphoribosylpyrophosphate in man: biochemical and clinical significance.
    Fox IH; Kelley WN
    Ann Intern Med; 1971 Mar; 74(3):424-33. PubMed ID: 4324023
    [No Abstract]   [Full Text] [Related]  

  • 60. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.